The SEC has also adopted regulations (Rule 14a - 8 under the Exchange Act) that govern the inclusion of
stockholder proposals in our annual proxy materials.
Alphabet's shareholder meeting last week resulted in a predictable outcome:
All stockholder proposals were voted down.
Thus, absent voting instructions from you, your broker may not vote your shares on the election of directors (Proposal 1), the advisory vote to approve named executive officer compensation (Proposal 2) or the adoption of the five
stockholder proposals (Proposals 4 through 8).
Absent your instructions, the broker will not be permitted, however, to vote your shares on the election of directors (Proposal 1), the advisory vote to approve named executive officer compensation (Proposal 2) or the adoption of the five
stockholder proposals (Proposals 4 through 8), and your shares will be considered «broker non-votes» on those proposals.
The NYSE does not consider the election of directors (Item 1), the advisory resolution to approve the named executives» compensation (Item 2) or any of
the stockholder proposals (Items 4 through 7) to be routine matters, so your broker may not vote on these matters in its discretion.
In addition to the election of directors (Item 1), the NYSE does not consider any of
the stockholder proposals (Items 5 through 8) as routine matters, so your broker may not vote on these matters in its discretion.
If you hold your shares in street name, it is critical that you cast your vote if you want it to count in the election of directors, the vote to approve the amendment to our Amended and Restated Certificate of Incorporation, the vote to approve the amendment and restatement of our 2013 Equity Incentive Plan, the advisory vote to approve named executive officer compensation, and
the stockholder proposals requesting: (i) the elimination of supermajority voting requirements, (ii) the adoption of a policy to consider employee pay ranges when setting CEO compensation, and (iii) a report on Salesforce's criteria for investing in, operating in and withdrawing from high - risk regions (Proposals 1, 2, 3, 5, 6, 7 and 8 in this Proxy Statement).
Please note that since brokers may not vote your shares on «non-routine» matters, including the election of directors (Proposal Number 1), the proposal to amend Google's 2012 Stock Plan (Proposal Number 3), and each of
the stockholder proposals (Proposals Number 4 through Number 8), in the absence of your specific instructions, we encourage you to provide instructions to your broker regarding the voting of your shares.
Please note that since brokers may not vote your shares on «non-routine» matters, including the election of directors (Proposal Number 1), the proposal to amend Alphabet's 2012 Stock Plan (Proposal Number 3), and each of
the stockholder proposals (Proposals Number 4 through Number 10), in the absence of your specific instructions, we encourage you to provide instructions to your broker regarding the voting of your shares.
The Board recommends a vote AGAINST
a stockholder proposal seeking to have us adopt a policy requiring that senior executives retain a significant percentage of stock acquired through equity pay programs until reaching retirement age because our existing stock ownership guidelines and other compensation policies already effectively facilitate significant stock ownership by our executives, and establishing holding requirements based on a particular retirement age would not be in the best interests of our stockholders.
Three proposals were voted on at the meeting: (i) stockholders voted to re-elect the four nominated Directors of MathStar's Board of Directors; (ii) stockholders ratified the appointment of MathStar's independent registered public accounting firm, PricewaterhouseCoopers LLP; and (iii) as had been recommended by the Board, stockholders rejected
the stockholder proposal recommending liquidation of MathStar.
Regarding
the Stockholder Proposal, Marathon Partners argued in its supporting statement that the Rights Agreement served no other purpose than to arbitrarily limit the number of shares a current or prospective shareholder could own at 10 % of the combined classes of stock.
Tang Capital Partners has ended its proxy contest by withdrawing its nominations of director candidates for election to VNDA's Board of Directors and
its stockholder proposal to liquidate VNDA.
Rockville, MD. (May 7, 2009)-- Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)(«Vanda» or the «Company») announced today that Tang Capital Partners, LP («TCP») has ended its proxy contest by withdrawing its nominations of director candidates for election to Vanda's Board of Directors and
its stockholder proposal to liquidate the Company.
TCP's withdrawal of its nominations and
stockholder proposal follows Vanda's announcement that the U.S. Food & Drug Administration had granted marketing approval of its product, Fanapt ™ (iloperidone), for the acute treatment of adult patients with schizophrenia.
Not exact matches
«Our
proposal provides Qualcomm
stockholders with a substantial and immediate premium in cash for their shares, as well as the opportunity to participate in the upside potential of the combined company,» Hock Tan, Broadcom's CEO, said in a statement.
«We continue to believe our
proposal represents the most attractive, value - enhancing alternative available to Qualcomm
stockholders and we are encouraged by their reaction,» Hock Tan, the president and chief executive officer at Broadcom, said in the statement on Monday.
Bethesda, MD and Stamford, CT, April 8, 2016 — Marriott International, Inc. (NASDAQ: MAR) and Starwood Hotels & Resorts Worldwide, Inc. (NYSE: HOT) announced that at separate special
stockholder meetings today the
stockholders of both companies approved
proposals relating to Marriott's acquisition of Starwood, which will create the world's largest hotel company.
In addition,
proposals submitted by shareholders for inclusion in TD Ameritrade's annual proxy statement, and
proposals submitted by
stockholders for presentation at TD Ameritrade's annual
stockholders meeting, will not be considered shareholder communications under this policy.
If
stockholders approve the
proposal, the Directors Plan will continue only as to the deferral program described below.
If
stockholders approve the
proposal to amend and restate the LTICP (see Item 4), each such share will count as three and one - half (3.5) shares.
Ahead of Tesla's annual shareholder meeting in June,
stockholder Jing Zhao has submitted a
proposal to replace the board's chairman, Elon Musk, with an independent director.
The Company's issuance of shares of common stock, including the additional shares that will be authorized if the
proposal is adopted, may dilute the equity ownership position of current holders of common stock and may be made without
stockholder approval, unless otherwise required by applicable laws or NYSE regulations.
The
proposal also may be harmful to the Company and its
stockholders because it could result in a fragmented and less effective Board.
We have long respected Mylan's business, and we are confident that Mylan's Board of Directors and
stockholders will agree that our
proposal represents a significantly more attractive alternative for Mylan and its
stockholders than Mylan's proposed acquisition of Perrigo.»
«Our
proposal would provide Teva
stockholders with very attractive strategic and financial benefits and Mylan
stockholders with a substantial premium and immediate value for their shares, as well as the opportunity to participate in the significant upside potential of the combined company — one that would transform the global generics space and leverage it to hold a unique leadership position in the pharmaceutical industry.
This
proposal seeks greater transparency, clarity, and understanding around how informed
stockholders vote on shareholder
proposals.
«Our
proposal is compelling for both Teva and Mylan
stockholders and other stakeholders,» said Erez Vigodman, President and CEO of Teva.
The
proposal's thresholds for nomination are too low and do not encourage Board representation focused on the long - term best interests of all FedEx
stockholders.
As a result of changes adopted by the NYSE to its broker voting rules, including changes mandated by the Dodd - Frank Act in connection with
stockholder votes on executive compensation matters, the NYSE does not consider the election of directors (Item 1), the advisory resolution regarding named executives» compensation (Item 2), and the advisory
proposal on the frequency of future advisory votes regarding named executives» compensation (Item 3) to be routine.
These provisions are intended to avoid costly takeover battles, reduce our vulnerability to a hostile change in control or other unsolicited acquisition
proposal, and enhance the ability of our board of directors to maximize
stockholder value in connection with any unsolicited offer to acquire us.
The
proposal, submitted by The Humane Society of the United States, represented the first time in American history that
stockholders of a corporation have utilized the shareholder resolution process to offer a company praise for its corporate responsibility work.
Keurig Green Mountain Parent Holdings Corp., Bob Gamgort (Director and Chief Executive Officer of Keurig Green Mountain Parent Holdings Corp.), Ozan Dokmecioglu (Chief Financial Officer of Keurig Green Mountain Parent Holdings Corp.), Bart Becht (a Director of Keurig Green Mountain Parent Holdings Corp.) may be deemed to be «participants» under SEC rules in any solicitation of Dr Pepper Snapple Group, Inc.
stockholders in respect of a Keurig Green Mountain Parent Holdings Corp.
proposal for a transaction with Dr Pepper Snapple Group, Inc..
As a result of the agreement, the Fund withdrew the shareholder
proposal it had filed for consideration at Goodyear's annual
stockholders» meeting, as well as with Nisource, which is one of the largest natural gas and electric utility companies in the United States.
We expect to receive additional
proposals in the weeks ahead and are optimistic about achieving our objective of creating significant value for all
stockholders.
Thus, the Board rejected PCI's Merger
proposal as not being in the best interests of MathStar's
stockholders.
Our Committee continues to believe this
proposal represents a unique opportunity for Avigen's
stockholders and we look forward to a prompt and favorable reply.
It was the Board's view that BVF's publicly - stated support for the MediciNova
proposal weakened Avigen's negotiating position, making it more difficult for Avigen to negotiate a better transaction with MediciNova on behalf of all of Avigen's
stockholders.
Please see «
Proposal No. 1 — Reasons for Removing Existing Directors — We believe the unilateral action by the Board to adopt a «poison pill» is an attempt by the Board and management to ensure the retention of their jobs and their compensation» for further discussion of Avigen's recently adopted
stockholder rights plan.
The strongest
proposals received to date include most of the following: (1) commercial or near commercial products; (2) revenue or near - revenue generating opportunity; (3) potential for sustainable operations without the need for equity financings; (4) sales and marketing support from a strong commercialization partner; (5) reduced remaining regulatory risk; (6) attractive growth potential; and (7) willingness to provide liquidity to Avigen
stockholders who need or prefer cash.
Why is the Board of Directors submitting a
proposal to the
stockholders to grant the Board authority to dissolve Aspen?
AVGN shareholders are to decide on BVF's
proposal to remove the board of AVGN and elect Biotechnology Value Fund's (BVF) slate of director nominees at a special meeting of
stockholders to be held this Friday, March 27, 2009.
We urge you to support your Board of Directors at the upcoming Special Meeting of Avigen
Stockholders on March 27, 2009 — by rejecting the proposal to remove your Board of Directors that is being presented to stockholders by Biotechnology Value
Stockholders on March 27, 2009 — by rejecting the
proposal to remove your Board of Directors that is being presented to
stockholders by Biotechnology Value
stockholders by Biotechnology Value Fund (BVF).
Aspen has called a meeting of its
stockholders for November 30, 2009, at which time it will present a dissolution
proposal for consideration.
Avigen Inc (NASDAQ: AVGN) has sent a letter sent to its
stockholders saying that Glass Lewis, a «leading independent voting advisory service» has reviewed the Biotechnology Value Fund (BVF)
proposal to remove AVGN's board and has recommended that
stockholders vote against the
proposal.
In response to that statement, the
stockholder withdrew his
proposal and the Securities and Exchange Commission was able to complete its review of the proxy statement for the May 22, 2009 meeting.
Avigen Inc (Nasdaq: AVGN) yesterday mailed a letter to
stockholders calling on them to reject the
proposal to remove AVGN's board being presented to
stockholders by Biotechnology Value Fund (BVF).
We intend to bring to
stockholders the strongest
proposal.
«* Three directors, Robert A. Cohan, Kevan B. Hensman and Douglas P. Imperato are continuing to evaluate whether they believe the Company can identify and execute on a business opportunity that may offer long term value to the Company's
stockholders and as such none have yet authorized the Board to make a recommendation for or against approval of
Proposal No. 2.»
Leading independent advisory service is recommending
stockholders vote AGAINST BVF's Board removal
proposal